Bone metastasis is a leading cause of morbidity and mortality in prostate cancer (PCa). While cancer stem-like cells have been implicated as a cell of origin for PCa metastases, the pathways which enable metastatic development at distal sites remain largely unknown. In this study, we illuminate pathways relevant to bone metastasis in this disease. We observed that cyclin A1 (CCNA1) protein expression was relatively higher in PCa metastatic lesions in lymph node, lung, and bone/bone marrow. In both primary and metastatic tissues, cyclin A1 expression was also correlated with aromatase (CYP19A1), a key enzyme that directly regulates the local balance of androgens to estrogens. Cyclin A1 overexpression in the stemlike ALDHhigh subpopulation of PC3M cells, one model of PCa, enabled bone marrow integration and metastatic growth. Further, cells obtained from bone marrow metastatic lesions displayed self-renewal capability in colony forming assays. In the bone marrow, Cyclin A1 and aromatase enhanced local bone marrow-releasing factors, including androgen receptor, estrogen and matrix metalloproteinase MMP9 and promoted hte metastatic growth of PCa cells. Moreover, ALDHhigh tumor cells expressing elevated levels of aromatase stimulated tumor/host estrogen production and acquired a growth advantage in the presence of host bone marrow cells. Overall, these findings suggest that local production of steroids and MMPs in the bone marrow may provide a suitable microenvironment for ALDHhigh PCa cells to establish metastatic growths, offering new approaches to therapeutically target bone metastases.
Malignant stem cells may arise within the normal stem cell population or through carcinogenic transformation of a differentiated cell type enabling the adoption of stem like features (1, 2, 3) . It is believed that only a subset of cells, termed cancer stem cells, are capable of initiating metastatic dissemination to distant organs (3) (4) (5) (6) . Cancer stem cells have been identified in malignancies including leukemia, brain, breast, colon and prostate cancers (PCa) as well (2, 4, (7) (8) (9) (10) (11) (12) .
In PCa, only rare, phenotypically distinct PCa tumor-initiating cells, also termed stem-like PCa cells have the capacity to form new tumors (4, (7) (8) (9) . Metastatic PCa remains a major clinical challenge, as most of PCa patients die from bone metastases (13, 14) . PCa are believed to favor the bone marrow, which are the unique sites enriched with hematopoietic cells, osteoblasts, stromal, extracellular matrixes and multiple cytokines (5, 13, 15, 16) . The stem-like PCa cells are believed to produce high levels of chemokine receptors which enable interaction of PCa with the infiltrated bone marrow cells to facilitate distant metastases (17, 18, 19) . The growth and metastases of stem-like PCa cells are also influenced by various types of steroid hormones including androgens and estrogens and their receptors (20) (21) (22) (23) (24) . Recent reported studies suggest that estrogen and its receptor ERα are present in the hematopoietic stem cells (HSC) and bone cells (25) (26) (27) . However, it remains largely unknown whether the steriod hormones may promote metastatic growth of the stem-like PCa cells in the bone marrow.
Aromatase is a steroid biosynthesis enzyme which is encoded by CYP19A1 gene, and catalyzes the conversion from androgens to estrogen (28) . Aromatase expression in prostate epithelial cells and the infiltrated inflammatory cells is induced by the cytokines, and is associated with the progression of prostate cancer (29). CYP19A1 expression is elevated in prostate cancer metastatic tissue with 30-fold higher than that in primary tumors (20, 22, 30) .
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The cell surface markers that recognize cancer stem cells provide possibility to study the unique mechanisms underlying cancer metastases in mouse models (31, 32) . Aldehyde dehydrogenase 1 (ALDH1) is a detoxifying enzyme responsible for the oxidation of intracellular aldehydes and has emerged as an ideal marker for isolation of stem-like cells from heterogeneous tumors (33) (34) (35) (36) . As the ALDH activity is increased in cancer stem cell populations isolated from multiple myeloma, acute myeloid leukemia (15) , breast cancer lung, head and neck, gastric and colorectal cancers and recently in PCa (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) , it is therefore considered as a reliable marker for isolation of cancer stem cells. Importantly, isolated ALDH high stem-like PCa cells initiate growth of tumors in orthotopic mouse models (41).
Cyclin A1 is an important cell cycle regulator and its expression is elevated in PCa (47, 48) . It acts as a co-regulator of AR on VEGF promoter activity to regulate VEGF expression (47, 48) .
Induced overexpression of cyclin A1 in PC3 cells initiated metastatic growth in lymph node, lung and liver in subcutaneous and orthotropic xenograft mouse models (48). In metastatic PC3 cells, cyclin A1 is functionally associated with VEGF and MMP2/MMP9 (48). Recently, we report that cyclin A1 interacts with ERα to promote breast cancer progression in xenograft mouse model (49) . Cyclin A1 function is required for hematopoietic stem and progenitor cells (HSPC) to home to their bone marrow niches (50) . In this study, we showed that ALDH high stem-like cells facilitate metastatic growth by utilizing cyclin A1 and aromatase to increase androgen to estrogen conversion and recruiting extracellular matrix metalloproteinases (MMP9) from the host bone marrow. Malmö. The mRNA expression data of cyclin A1 and aromatase (CYP19A1) were extracted from the cBioPortal database with GEO accession number: GSE21032 as described (51, 52) .
The study was approved by the Ethics Committee, Lund University, and the Helsinki Declaration of Human Rights was strictly observed.
Immunohistochemistry Analysis
Immunohistochemistry on tumor tissue arrays was performed as previously described (47) .
The staining procedure was performed using a semiautomatic staining machine (Ventana ES, Ventana Inc., Tucson, AZ) as previously described (48).
Cell culture and Generation of vectors and stable and transient transfection
An androgen-insensitive cell line, PC3M cells were kindly provided by Dr. J Fidler (Department of Urology, MD Anderson Cancer Center, Houston, Texas, USA) (53) . The cell lines were authenticated by the suppliers. The PC3M cells were received 2011, and freshfrozen stocks were used. The total span of years in using PC3M cells in our labs is approximately three years. For transient transfection studies, pMSCV-cyclinA1-EGFP was generated by cloning the full-length (1.8 kb) human cyclin A1 cDNA into the EcoRI site of the pMSCV-EGFP construct (Clonetech Inc.).
PC3M cells were cultured in polyhema-coated flasks at 5000/ml in spheroid medium modified from protocols used for mammo-sphere formation as described (54) . To generate second passage spheres, cells derived from the first passage spheres were plated again at a density of 5x10 3 cells/ml and grown in culture medium for 7 days as mentioned above.
ALDEFLUOR assay
The ALDEFLUOR kit (StemCell Technologies, Vancouver, Canada) was used to isolate the population with a high ALDH enzymatic activity (stem-like ALDH high cells) according to manufacturers' protocol. Cells were stained with 7AAD (BD Biosciences, San Jose, CA, USA) to distinguish viable cells from dead cells and analysis on CyAn™ ADP flow cytometer or FACS Aria (Beckman Coulter). FACS data were analyzed using FCS Express software (DeNovo Software, CA).
Mouse model of PCa distant metastases
The animal studies were approved by the Swedish Regional Ethical Animal Welfare Committee and the guidelines were strictly followed. Athymic NMRI nude male mice aged 8-12 weeks (Taconic Europe, Denmark) were used. For intravenous injection of tumor cells, mice were sub-lethally irradiated with two doses of 2 Gy administered 2 hours apart using a 137 Cs source at a dose rate of 1Gy/min as described (55) . Equal amount of ALDH high cells (1x10 5 cells /mouse) or unsorted PC3M cells (2x10 6 cells/mouse) were injected into mice via tail-veins. For intracardiac injection, 1x10 5 cells /mouse were injected into the left ventricle of anaesthetized mice (1% isoflurane through inhalation). In vivo imaging device (IVIS imaging system, PerkinElmer). For HLA-ABC antibody-based imaging, mice were injected intraperitoneally with 30 µg of HLA-ABC antibody conjugated with 680 DyLight NHS-ester (LifeTechnologies) (56) . 
Identification of metastatic PCa cells in the bone marrow of mice by FACS
To identify metastatic PCa cells in the bone marrow of irradiated recipients after transplantation, bone marrow cells from long bones of the recipient mice were isolated and were assessed using FACS methods as described (50) .
Evaluation of ability of single cells from metastatic tumors of mice to form colony-forming unit using methylcellulose-based medium
To assess the repopulating ability and differentiation potential of the BM progenitor cells or metastatic PCa cells in the bone marrow, we used a methylcellulose-based colony-forming assay according to the manufacturer's description (MethoCult™, Stem Cell Technologies).
Colonies containing 30 and more cells were scored after 14 days.
Immunofluorescence analysis
For immunofluorescence analysis, cell suspensions were fixed on slides in 4% paraformaldehyde (Merck KGaA, Germany) for 15 minutes at room temperature (RT). The slides were stained with primary antibodies including anti-HLA (Biosite) and anti-cyclin A1 (BD Pharmingen).
Treatment of ALDH high or ALDH low cells with 17-β-estradiol or DTH
For estrogen treatment, ALDH high or ALDH low populations were sorted from PC3M cells and were maintained in 10% charcoal stripped phenol red free medium (CSS) (Gibco, Life Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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Co-culture of ALDH high or ALDH low cells with the bone marrow and measurement of estradiol production
For MTS assay, ALDH high or ALDH low cells were cultured in serum-free phenol red free RPMI medium containing 50% of the bone marrow extracts of NMRI-nude mice. The cells were cultured for 48 hours and were subjected for MTS assay. For measurement of estradiol production, Estradiol Assay kit (R&D Systems Ltd, Abingdon, UK) was used according to the manufacturer's protocol. For treatment with Aromatase inhibitor, Type I aromatase inhibitor (Merck Millipore) was used at 100 nM concentration. Concentrations were determined by measuring absorbance on an Infinite M200 multimode microplate reader (Tecan Sunrise).
Testosterone and estradiol levels were determined using an immunoassay from Roche Diagnostics (Estradiol III) on a Cobas 6000 Analyzer (Roche Diagnostics, USA).
Statistical analysis
Statistical analysis was performed. Distribution of overall survival (OS) was estimated by the method of Kaplan-Meier, with 95% confidence intervals. Differences between survival curves were calculated using the log-rank test using statistical program (SPSS, 16.0).
Description of experimental procedures and methods are given in Supplemental Materials and
Methods (Supplemental Information).
Results

Expression of cyclin A1 and aromatase in patients with PCa
Author Manuscript Published OnlineFirst on February 26, 2016; DOI: 10.1158/0008-5472.CAN- Immunohistochemical analysis was performed to assess protein expression of cyclin A1 and aromatase on tissue microarrays (TMAs) consisting of begin prostate hyperplasia (BPH) (n=48 patients), primary PCa (n=65) and metastatic PCa in lymph nodes, bone marrows and lungs (n=43) from 14 PCa patients who suffered bone metastasis. Cyclin A1 expression was predominantly nuclear, while aromatase expression was cytoplasmic in primary and metastatic PCa tissues ( Figure 1A ). Expression of cyclin A1 was higher in primary PCa than in BPH (for cyclin A1, p<0.001) ( Figure 1B ). Metastatic lesions displayed increased cyclin A1 expression compared with that of primary PCa (p=0.019) ( Figure 1C ). Although aromatase expression did not show significant increase in metastatic PCa compared with primary tumors ( Figure 1C ), it was significantly higher in primary PCa than in BPH (p=0.001) (Figure 1 B) . Further, expression of cyclin A1 was positively correlated with aromatase expression in both primary and metastatic PCa as determined by Spearman's rank correlation test (R 2 = 0.398, p< 0.001).
We next examined mRNA expression of cyclin A1 and aromatase using a PCa cohort consisting of primary (n=131) and metastatic (n=19) PCa tissues extracted from the public available databases (51) . Cyclin A1 and aromatase mRNA expression remained to be similar between primary and metastatic PCa tissues ( Figure 1D ). Somatic mutations or amplifications in genes encoding cyclin A1 and aromatase appeared to be rare. Only 4% (8 out of 216) amplifications in gene encoding for cyclin A1 and 2% (4 out of 216) amplifications in CYP19A1 gene were observed ( Figure 1E ). This suggests that overexpression of cyclin A1 and aromatase in PCa may be due to the alterations at protein levels. Nevertheless, we observed that a subset of patients with higher CYP19A1 expression suffered poorer BCR-free survival as compared with those with lower CYP19A1 (p<0.001) ( Figure 1F ). Cyclin A1 expression was not associated with disease-free survival of PCa patients in these two cohorts (p=0.348) ( Figure 1F ).
Cyclin A1 promoted growth of "tumor spheres" in vitro
The stem-like ALDH high and non-stem-like ALDH low subpopulations of PC3M cells were sorted by FACS using the ALDEFLUOR assay (Figure 2A and B) , and were examined for the expression of cyclin A1 and aromatase. Both ALDH high and ALDH low cells expressed cyclin A1 and aromatase ( Figure 2C ). Next, the role of cyclin A1 in tumor-initiating property of stem-like cells was assessed. We employed 3-demension (3-D) culture systems, as this method is well-established for assessment of breast cancer stem cells (57, 58) . PC3M cells that were stably transfected with pMSCV-EGFP or pMSCV-EGFP-A1 were seeded in 3-D medium and were cultured for a period of 7 days. One of the characteristics of the stem-like cells is the ability to form "tumor spheres". PC3M cells expressing cyclin A1 formed larger size of "tumor spheres" with increased cell numbers as compared with the controls (p=0.03) ( Figure 2D and E). We next re-plated the single cell suspensions prepared from the spheres to test their self-renewal ability. The re-plated cells expressing cyclin A1 again formed larger spheres with higher cell numbers compared with the controls (p=0.015) ( Figure 2D and E).
Further, PC3M cells expressing cyclin A1 contained higher frequency of ALDH high subpopulation (5.43±2.69%) with approximately 3-fold increase compared with the controls (1.89±0.85%) (p<0.001) ( Figure 2F ). This data suggests that PC3M cells contain stem-like cells and that cyclin A1 overexpression increases frequency of the tumor-initiating cells in vitro. To investigate whether the ALDH high stem-like cells may invade to the bone marrow, we established an in vivo mouse model. Nude mice were sub-lethally irradiated with low dose γirradiation to inhibit host immune function prior to the transplantation of the tumor cells. We observed that expression of aromatase and ERα was higher in ALDH high cells overexpressing cyclin A1 compared with the controls (Figure 3A) . Equal amount of ALDH high subpopulations sorted from PC3M cells expressing the vectors were introduced into the irradiated mice via intravenously injection ( Figure 3B ). The human HLA-ABC antibody conjugated with fluorescent dye was administrated into the mice for bioluminescent in vivo imaging analysis ( Figure 3C ). Tumors that were positive to HLA-ABC fluorescent antibody were detected in both groups of mice using imaging device after 80 days post-transplantation ( Figure 3C ). We performed FACS analysis and confirmed that the transplanted cancer cells positive to HLA-ABC integrated into the bone marrow ( Figure 3D ). There was clear trend that a higher frequency of ALDH high cells overexpressing cyclin A1 homed the host bone marrow compared with the controls (n=4 mice/per group) (P=0.076) ( Figure 3D ).
Cyclin A1 and aromatase promote metastatic dissemination of ALDH high stem-like cells to the bone marrow in mouse xenografts
Since the FACS analysis is dependent on the quality of HLA-ABC antibody and its ability to bind tumor-producing HLA-ABC antigens in vivo, therefore this method represents certain difficulties with large variations. We therefore examined expression of cytokeratins that specifically recognize human PCa cells in the bone marrow ( Figure 3E) . A significantly higher number of cytokeratins-positive cells and Ki-67-positive cells was observed in the bone marrow of mice which received ALDH high cells expressing cyclin A1 vector (for cytokeratins, p=0.024; for Ki-67, p<0.001) ( Figure 3E , F, G and H). These data showed that ALDH high cells integrated into the bone marrow and that cyclin A1 overexpression enhanced metastatic growth of the ALDH high cells.
Author Manuscript Published OnlineFirst on February 26, 2016; DOI: 10.1158/0008-5472.CAN- We transplanted unsorted PC3M cells expressing cyclin A1 or EGFP vector into the irradiated mice via intravenous injection. Metastatic tumors in prostate, lung and liver appeared in 3 out of 5 mice which received PC3M cells expressing cyclin A1, while a large subcutaneous tumor was formed near the proximal end of the tail in 1 out of 5 control mice (Supplemental Figure   1 ). There was a clear trend that elevated levels of cyclin A1 in tumors were positively correlated with poorer overall survivals of the xenograft mice (Supplemental Figure 1) . No metastases to the bone marrow were detected in these xenograft mice. We therefore induced unsorted PC3M cells expressing cyclin A1 or EGFP vectors into mice via intracardiac injection which allows tumor cells entering directly into systemic circulation, and homing to the bone marrow. Tumor metastases were detected in both groups of mice after 33 days posttransplantation (5 mice/group) using bioluminescent in vivo imaging analysis (Supplemental Figure 2A and B) . FACS analysis revealed that HLA-ABC-positive PC3M cells integrated into the bone marrow (Supplemental Figure 2C and D). Overexpression of cyclin A1 increased frequency of PC3M homing to the bone marrow relative to controls, as determined by using cytokeratins-stainings of tumor cells (P= 0.016 for CK5 and P= 0.0014 for CK20) (Supplemental Figure 3) .
Metastatic growth of ALDH high PC3M cells in the bone marrow through cyclin A1 and aromatase associated pathways
We next wanted to assess whether metastatic lesions initiated by ALDH high PC3M cells may retain stem-like properties such as self-renewal and differentiation. We isolated bone marrow cells from the mice bearing bone marrow metastases initiated by ALDH high cells expressing cyclin A1 or control vector. The isolated bone marrow cells were then subjected to colony formation Unit (CFU) assay in the semi-solid MethoCult™ medium which is commonly used for assessment of self-renewal and differentiation ability of the hematopoietic cells ( Figure   4A ). Bone marrow cells containing PCa metastatic lesions isolated from the mice (4 mice/group) formed colonies ( Figure 4B ). To access whether the CFUs might be derived from both host hematopoietic stem/progenitor cells, and metastatic ALDH high cells, single cell suspensions were prepared from the colonies and were examined for the co-expression of cyclin A1 and HLA-ABC, a specific human tumor antigen. We observed that the subset of cells collected from the CFUs indeed co-expressed cyclin A1 and HLA-ABC, and the signals were enhanced in cells overexpressing cyclin A1 ( Figure 4C ). By using the combination of Giemsa staining and visualization of EGFP positivity in CFUs, we further identified CFUs derived from ALDH high cells ( Figure 4D , E, F and G). This suggests that the metastatic lesions derived from ALDH high cells are able to self-renewal and repopulate into new tumor cells in CFU assays, and this characteristic is similar to the host bone marrow hematopoietic stem/progenitor cells. Further, we observed that there was a higher proportion of PCa cells in the CFUs derived from the bone marrow samples of mice bearing metastases with elevated level of cyclin A1 as compared with the controls (p<0.001) ( Figure 4H ). These new findings showed that the metastatic lesions derived from ALDH high PC3M cells retained self-renewal and repopulating properties.
We examined the expression of aromatase and ERα in the CFUs derived from the metastatic bone marrow of the xenograft mice. Expression of aromatase and ERα retained in the CFUsderived from the metastatic lesions initiated by the ALDH high cells, and was enhanced by overexpression of cyclin A1 (Figure 4I Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on February 26, 2016; DOI: 10.1158/0008-5472.CAN-15-2340 marrow microenvironment. We observed that overexpression of cyclin A1 was positively associated with the decreased apoptosis, as determined by examining the expression of cleaved caspase-3 in the CFUs derived from the metastatic PCa lesions ( Figure 4L ).
Cyclin A1 overexpression in ALDH high cells increased MMP9 expression in the bone marrow cells
We further examined aromatase expression in series bone marrow sections of the xenograft mice bearing metastases using immunohistochemical analysis. Approximately 10% aromatase-positive cells were observed in the metastatic bone marrow of control xenograft mice ( Figure 5A and B) . Overexpression of cyclin A1 increased aromatase-positive cells by 60% (p<0.001) and staining intensity of aromatase ( Figure 5A, B and C) . The integration of ALDH high cells overexpressing cyclin A1 into the bone marrow significantly increased MMP9 expression in the host bone marrow (p=0.016) ( Figure 5D , G and H). Similar to AR, MMP9 expression was absent in ALDH high cells, but was present in the host bone marrow cells ( Figure 5E and F) . These data suggest that ALDH high cells with elevated level of cyclin A1 influence the bone marrow-releasing factor such as MMP9.
ALDH high stem-like subpopulation of PC3M cells are more sensitive to aromatase inhibition than the ALDH low cells
We further investigated whether the ability of ALDH high cells to initiate metastatic growth in the bone marrow is related to their stem-like characteristics with growth advantages. We subjected equal amount of ALDH high and ALDH low cells sorted from PC3M cells expressing EGFP-cyclin A1 or control vectors to the MTS-based proliferation assays. The growth rate of ALDH high subpopulation was significantly higher with 20% increase compared with the ALDH low cells (p=0.012) ( Figure 6A ). Overexpression of cyclin A1 increased growth of Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on February 26, 2016; DOI: 10.1158/0008-5472. CAN-15-2340 ALDH high cells by 60% as compared with the ALDH low cells (p<0.001) ( Figure 6A ). Further, overexpression of cyclin A1 increased growth rate only in ALDH high cells (p=0.012) but not in ALDH low cells ( Figure 6A ). This suggests that ALDH high cells with cyclin A1 overexpression have growth advantages over that of ALDH low cells. Next, we inhibited aromatase production in ALDH high vs. ALDH low cells using an irreversible type I aromatase inhibitor. Inhibition of aromatase reduced proliferation of control ALDH high cells (p=0.008) and ALDH high cells overexpressing cyclin A1 (p<0.001) ( Figure 6B ), but had no significant effect on ALDH low cells. We further examined the effect of bone marrow microenvironment on the growth of ALDH high vs. ALDH low cells. We co-cultured equal amount of the sorted cells with the bone marrow extracts of mice. ALDH high cells displayed higher ability to adapt and grow in the bone marrow-containing medium compared with the ALDH low cells as determined by MTS proliferation assays ( Figure 6C ). Overexpression of cyclin A1 significantly enhanced ability of ALDH high cells, but not that of ALDH low cells to grow in the bone marrow-containing medium ( Figure 6C ). Next, we measured the concentration of estradiol, an end product of androgen to estrogen conversion, in ALDH high PC3M cells, in bone marrow cells alone and in co-cultures of ALDH high PC3M cells and bone marrow cells.
Estradiol levels in ALDH high PC3M cells cultures were similar to that in the medium only (RPMI1640 containing 10%FBS) ( Figure 6D ), suggesting that ALDH high PC3M cells do not produce detectable levels of estrogen in vitro. Bone marrow cells produced detectable levels of estradiol, which were significantly increased in co-culture with ALDH high (Figure 6D and E). Overexpression of cyclin A1 further increased estradiol production (for BM alone vs. coculture of BM and ALDH high cells expressing EGFP, P<0.001; for co-culture of BM and ALDH high cells expressing EGFP-A1 vs co-culture of BM and ALDH high cells expressing EGFP, P=0.029) ( Figure 6D ). Inhibition of aromatase by aromatase inhibitor in ALDH high cells overexpressing cyclin A1 prior to the co-culture with the bone marrow cells in serum- free medium led to a significantly reduction in estradiol level in the co-culture (p<0.001) ( Figure 6E ).
Discussion
Increasing evidence has suggested that cancer stem cells are the cell origin to initiate distant metastases (4, 5, 59) . However, the unique cellular pathways that enable cancer stem cells to establish metastatic lesions into the distant organs remain largely unknown. In this study, we observed that cyclin A1 protein expression was significantly higher in PCa metastatic lesions from PCa patients. In agreement with the previous reported study (60) , our data also showed that aromatase was abnormally expressed in human PCa. Expression of both cyclin A1 and aromatase proteins was significantly higher in primary PCa than in BPH. A subset of patients with upregulated aromatase mRNA expression suffered poorer BCR-free survival, although this finding was limited to fewer patients. Nevertheless, our present study adds new information on the clinical importance of aromatase expression in PCa progression.
In this study, we found that ALDH high subpopulation of PC3M cells had higher growth ability compared with ALDH low subpopulation. It has been shown that γ-radiation at low dose (2) (3) (4) Gy) promoted tumor cell infiltration with no pronounced impact on host immune function in nude mice (55) . The ALDH high subpopulation accounted for 1.89±0.85% of total PC3M cells Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on February 26, 2016; DOI: 10.1158/0008-5472. CAN-15-2340 like cancer cells to bone. Our findings are in agreement with the reported studies in breast cancer (37) (38) (39) and PCa (40, 41) , which suggest that rare subsets of cancer cells are sufficient to initiate metastases to distant organs.
Although ALDH high PC3M cells alone are sufficient to initiate metastases into the bone/bone marrow, overexpression of cyclin A1 increased frequency of the integrated ALDH high cells by 40-50%. These findings are coincident with that overexpression of cyclin A1 promoted proliferation of ALDH high subpopulation, but not ALDH low subpopulation. Aromatase facilitates the metabolism of testicular testosterone and androstenedione to estrogen, and directly regulates the local balance of androgens to estrogens (61) . Growing evidence suggests that the microenvironment has profound effects on cancer metastases to preferential tissues/organs. Aromatase is able to utilize exogenous testosterones and extracellular factors from the tumor-associated microenvironment to produce estradiols and other hormones (29).
We found that the expression of bone marrow-releasing factors including AR, ERα, MMP9 was induced as a result of metastatic integration of ALDH high cells. Our new data show that increased aromatase activity in ALDH high population in the context of the bone marrow microenvironment enhances estradiol production. Moreover, incorporation of a pharmacological inhibitor establishes the requirement for aromatase in estradiol production in our model. Overexpression of cyclin A1 further increases estradiol production, providing insight into how cyclin A1 overexpression in ALDH high cells can influence the tumor microenvironment in the bone marrow niches. We were unable to detect significant changes in the steady state levels of androgens in mono-or co-cultures of ALDH high cells and bone marrow cells (data not included). Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on February 26, 2016; DOI: 10.1158/0008-5472. CAN-15-2340 Our study suggests that cyclin A1 is a key factor that regulates aromatase-associated pathways. However, the precise cellular mechanisms by cyclin A1 regulates aromatase expression remain to be further explored in the future studies. Taken together, our data suggest that the stem-like PCa cells express high levels of several key factors that facilitate metastatic homing to the bone marrow environment. Our study will provide new insights into the PCa bone metastases and help to design novel targeted therapy. 
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